Patient Care
Perinatal period section
Our hospital has been designated by Tokyo Metropolitan as a “Perinatal Medical Center”, and has an obstetric inpatient ward including maternal-fetal intensive care unit (MFICU) and neonatal intensive care unit (NICU). We are responsible for the following cares.
- Accepting maternal and neonatal transport
- Maternal critical care
- High-risk pregnancy care
- Advanced neonatal care
Gynecological Tumor Section
We are in charge of total medical care from diagnosis to treatments, as specialists in gynecological cancer (specialist in gynecologic tumor/certified general clinical oncologist). We aim for radical cures for all sorts of gynecological cancer. For advanced cancer, multidisciplinary therapy including extended surgery, chemotherapy, and/or radiotherapy is performed. For early-stage cancer, we perform minimally invasive surgery preserving function. We provide accurate treatments through personalized medical care using biomarkers for advanced cancer, where it is particularly difficult to obtain radical cure outcomes. Furthermore, we not only focus on patients’ QOL and choosing effective treatments, but also proactively perform “cancer genomic medicine”, the latest treatment for recurrent cancer. We strive for patient satisfaction by providing not only standard therapy based on evidence, but also treatments which meet patients’ needs. We have been providing medical care every day from the perspective that “if the patient were a member of my family…”
Endoscope Section
Endoscopic surgery (laparoscopic surgery/hysteroscopic surgery) is low-invasive compared with laparotomy, so it enables less postoperative pain, short hospitalization period, and better cosmetic appearance. We perform 400 endoscopic surgery a year for benign diseases which accounts for most of the benign diseases treated in this hospital, including around 200 cases of uterine fibroid, 130 cases of ovarian tumor, 30 cases of hysteroscopic surgery, and others. Currently we can perform surgery without a long waiting period thanks to our capacity for surgery. We take advantage of our strength as a university hospital to perform laparoscopic detailed examinations for infertility and ovarian cancer in cooperation with our reproduction center and malignant tumor team. We have been expanding applicability of laparoscopic surgery for more diseases.
Reproduction Section
We provide entire reproductive medicine ranging wide from infertility treatment to oncofertility care and fertility sparing surgery. For infertility treatment, gynecology and urology staff work together and provide various advanced assisted reproductive technology (ART) such as IVF (in vitro fertilization), ICSI (intracytoplasmic sperm injection), MD-TESE ICSI (microdissection testicular sperm extraction) for azoospermia, and hysteroscopic / laparoscopic surgery. Our hospital is a facility certified by the Japan Society of Obstetrics and Gynecology for PGT-A (preimplantation genetic testing for aneuploidy) and PGT-SR (preimplantation genetic testing for structural rearrangements). We have clinical genetic unit which provides specialized counseling. Furthermore, we conduct egg freezing, sperm freezing, and embryo freezing for cancer patients who are concerned about a decline in ovarian function caused by chemotherapy and/or radiotherapy. We are the certified facility for the techniques.
Clinical Genetics Unit
Our Clinical Genetics Unit provides the following tests in cooperation with relevant sections.
- Prenatal diagnosis including NIPT (Noninvasive prenatal genetic testing), combined screening, chromosome analysis of amniotic fluid, etc. with the obstetrics section and the recurrent pregnancy loss section.
- Chromosome analysis for infertility, AZF (Azoospermia factor) deletion, PGT-A (preimplantation genetic testing for aneuploidy), PGT-SR (for structural chromosomal rearrangements), PGT-M (for monogenic disorder) with the reproduction section.
- Cancer genomic medicine using NCC Oncopanel, FoundationOne CDx®, etc., and BRCA1/2 genetic testing and genetic counseling for familial tumors such as HBOC (Hereditary Breast and Ovarian Cancer) with the tumor section.